Objective. To identify factors associated with no analgesic treatment in community-dwelling older adults with mild-to-moderate dementia and moderate-tosevere pain.
factors such as depressive symptoms influenced the relationship between pain interference and pain treatment. Those with less pain interference were more likely to have no analgesic treatment (OR 5 1.04, 95% CI 5 1.01-1.08), but only if they had lower levels of depressive symptoms (b 5 -0.52, P 5 0.005).
Introduction
More than 5 million older adults in the United States suffer from dementia [1] , and the majority of cognitively impaired older individuals reside in the community [2] . Pain occurs in 25-50% of community-dwelling older adults with dementia [2] [3] [4] , which is similar to the rates of pain seen among elders living in nursing homes [5] and in those who are cognitively intact [6] . Although best practice guidelines have emphasized the importance of routine pain assessment in older persons with dementia [7] , pain is still under-recognized and undertreated in this population.
Most studies that have described the undertreatment of pain have focused on older adults in medical or longterm care facilities [8, 9] . For example, dementia patients admitted to a hospital with hip fractures received onethird of the amount of opioid analgesia as their cognitively intact counterparts [10] . Cognitively impaired longterm care residents had significantly fewer scheduled pain medication orders and received significantly less pain medication than residents who were cognitively intact [11] . Although few studies have described the undertreatment of pain in nonresidential patients, recently completed analyses from our group that examined the quality of care in these persons highlighted a lack of pain recognition, underuse of appropriate assessment tools, discrepancies implementing best medication practices, and low use of nonpharamcological pain interventions as important barriers to successful pain management [12] .
Identifying individual and contextual variables that influence the undertreatment of pain in community-dwelling older adults with dementia is a critical first step toward improving the assessment and treatment of pain in this population. The Behavioral Model of Health Service Utilization, a multilevel model that incorporates individual and contextual determinants of health services use [13, 14] , posits that predisposing characteristics (i.e., demographic, social, and mental health factors), enabling characteristics (i.e., financial and organizational factors), and need factors (i.e., perceived need, evaluated need, environmental need, and population health indices) are three major components that can predict health care use.
A similar framework could be used to examine factors associated with no analgesic treatment. Predisposing characteristics such as sociodemographic variables (e.g., age, gender, minority status) and enabling characteristics such as financial resources may influence who is most likely to pursue pain treatment. For example, people who are older, members of racial minorities, and poorer have less access to health care than their younger, white, more affluent counterparts [15] [16] [17] . Need characteristics such as an individual's perception of his/her physical, emotional, and functional health status [13] may also interfere with the recognition and treatment of pain in this population. Although self-reported pain appears to be accurate in many people with mild-to-moderate dementia [18] , dementia-associated deficits in memory, language, and abstract thinking become more prominent as the disease progresses. As a result, it becomes increasingly difficult for people with dementia to recall their pain experiences accurately [19, 20] , especially if painful conditions are not controlled [20] . Therefore, many people with dementia who remain in the community rely on a care partner who serves as a proxy rater at routine medical appointments. However, proxy reports can be misleading because proxies are not always educated about what behaviors indicate pain [21] .
Another "need characteristic" that may play a particularly influential role in whether or not pain is recognized and treated is how much pain interferes with routine activities. Among home-dwelling older adults, the prevalence rate for pain significant enough to interfere with routine activities was significantly lower in people with dementia (19%) than in people without dementia (36%), and the people with dementia were also less likely to use analgesics (33%) than their nondemented counterparts (47%) [22] . It is not clear why those with dementia reported less pain interference; however, it is possible that they were underreporting their pain experiences and, as a consequence, were less likely to get treatment. It is also possible that there are factors that influence the relationship between pain interference and analgesic use in this population, buffering their association. For example, depression and related factors, such as social isolation, sleep disturbance, functional impairment, decreased enjoyment in life, and altered social relationships have been linked to pain among the community-dwelling elderly [23] and may exacerbate pain-related symptoms. This may result in making pain and somatic symptoms more easily recognizable in those with higher levels of depression. Consequently, those with higher levels of pain-related interference and such comorbidities may be more likely to receive Pain Among Community-Dwelling Older Adults with Dementia analgesic treatment than those with pain-related interference without such comorbidities. However, examination of depressive symptoms as a moderator of the relationship between pain interference and analgesic use has not been explicitly studied. This study, guided by the Behavioral Model of Health Service Utilization, sought to examine potential predictors that contribute to no analgesic treatment in a sample of community-dwelling older adults with dementia and moderate-to-severe pain. We hypothesized that "predisposing factors" such as an older age, female gender, minority status, lower educational level, and care partner relationship (not married), "enabling factors" such as a lower income, and "need characteristics" such as lower levels of pain interference, depressive symptoms, and cognitive functioning would predict lack of analgesic treatment in this population. We also explored the potential moderating role of depressive symptoms on the relationship between pain interference and no analgesic treatment.
Methods

Participants and Procedures
Participants in this study, community-dwelling veterans with moderate-to-severe pain and dementia and their care partners, were enrolled in a randomized clinical trial of the effectiveness of a home-based psychoeducational pain intervention, which focused on decreasing the incidence of aggressive behavior in people with dementia at increased risk of behavioral disturbance due to pain [24] . Care partner and patient with dementia dyads were randomly assigned to the psychosocial intervention or enhanced primary care. The weekly psychosocial intervention involved eight 45-minute home visits (i.e., a total of six intervention hours), which included carepartner instruction on recognizing pain, enhancing carepartner communication skills, and care-partner instruction on how to incorporate pleasant and enjoyable activities for the care recipient.
Potential participants were identified by 1) a search of the Veterans Health Administration (VHA) Outpatient Data for persons with a diagnosis of dementia, 2) an active prescription of medication indicated for dementia, or 3) a provider referral to the study. Potential participants received opt-out letters, and follow-up screening calls determined whether veterans met the following inclusion criteria: 1) documented diagnosis of dementia; 2) receipt of primary care from the VHA; 3) residence outside a long-term care facility; 4) residence within 50 miles of the Michael E. DeBakey VA Medical Center in Houston, Texas; 5) mild-to-moderate dementia (excluding advanced dementia because care partners experiences are typically qualitatively different for these individuals)-mild-to-moderate dementia was defined as having a stage of 2-6 on the Functional Assessment Staging (FAST), a well-validated clinician-rated measure of functional decline in dementia [25] , which captures gross functional impairments commonly seen among those with severe cognitive impairment; 6) no history of aggression in the past year, given that the aim of the intervention in the parent study was to prevent the development of aggression among individuals with pain; 7) having a care partner who was directly involved with the veteran at least eight hours per week, saw the veteran at least twice per week, and spoke English; and 8) positive pain screen for "moderate-to-severe pain" by either self-report or a care partner's report, defined as a response of two or higher to this question from the Philadelphia Geriatric Pain Intensity scale [26] , a wellvalidated measure in persons with dementia [27] : "Over the last several weeks, which one describes how bad your (or your loved one's) pain has been overall?" with a response scale of 0 (no pain) to 5 (unbearable pain). This question was accompanied by presentation of the response scale in the form of a thermometer graphic. Veterans who were eligible and agreed to participate completed written consent forms and phone-based baseline assessments from which these data were taken.
Baseline Measures
Predisposing Characteristics
Predisposing factors included age, gender, race, educational level, and the care partner relationship. Participant characteristics were obtained via participant and care partner report.
Enabling Characteristics
Income was considered an enabling factor. Information regarding income was obtained via participant and care partner report.
Need Characteristics
Need characteristics included pain interference, depressive symptoms, and cognitive functioning. One continuous item from the Philadelphia Geriatric Pain Intensity Scale, a well-validated measure of pain in older adults [26] , was used to capture care partner-reported pain interference. Care partners were asked, "To what extent does your loved one's pain interfere with his/her daily activities?" Care partners answered this question on a five-point scale: 0 ¼ "not at all," 1 ¼ "a little," 2 ¼ "some," 3 ¼ "quite a bit," and 4 ¼ "a great deal." Depressive symptoms were measured using the Geriatric Depression Scale (GDS) [28] , an instrument designed to assess depression in geriatric populations. Scores range from 0 to 30, and scores of 10 or greater are possible indicators of depression. The GDS is validated for use in individuals with dementia [28, 29] and with collaterals over the phone [30] . Due to concerns regarding burden for participants with dementia, as well as concerns about the underreporting of depression in some dementia populations [31] , care partners answered items as the veterans' proxies. In the current study, the scale had high reliability (Chronbach's a ¼ 0.87).
Cognitive functioning was assessed with the Short Blessed Test [32] , a six-item continuous measure that captures early cognitive changes associated with dementia. Higher scores indicate greater cognitive impairment. It was derived from the full Blessed test and is well-validated.
Analgesic Treatment
Pain treatment was defined as analgesic medication prescribed or documented as being taken. Medical records were collected from VHA Outpatient Data records from six months before to six months after (12 months total) each person's baseline assessment. Medication lists were taken from the record closest in time to the baseline assessment date. Abstracted records included notes from primary care, geriatric outpatient clinics, nursing, and mental health/psychiatric outpatient clinics. All medical reviews were performed by a trained research assistant, guided by written abstraction guidelines and on-site consultation from a geriatric psychiatrist. Prescription and over the counter medications were recorded during abstraction from the medical record. Pain medications were separated into three classes, based on the World Health Organization's Analgesic Ladder (nonsteroidal anti-inflammatory drugs [NSAIDS]/acetaminophen, weak opioids, and strong opioids). Analgesic treatment was considered to be whether or not pain medication was prescribed or documented as being taken, and data were analyzed as a dichotomous variable (yes vs no).
Data Analyses
A series of hierarchical logistic regression models was used to examine 1) individual and unique associations between predisposing, enabling, and need characteristics and no analgesic treatment (Aim 1) and 2) the relationship between depressive symptoms and pain interference in predicting no analgesic treatment (Aim 2). Age was analyzed as a continuous variable. Race (white and not white), education (below college and above college), and care partner relationship (married and not married) were analyzed as dichotomous variables. Income (in thousands of dollars) was analyzed as a continuous variable. We began by conducting 10 separate logistic regression models to examine the individual association between each of the predisposing, enabling, and need characteristics and the likelihood of no analgesic treatment (Aim 1). Variables that were related to the outcome at a P value of less than or equal to 0.25 were then entered simultaneously into a single multiple logistic regression model [33] .
We then examined the interaction between depressive symptoms and pain interference in predicting no analgesic treatment (Aim 2) by entering variables into the model in two separate steps.
Step 1 included the main effects of depressive symptoms and pain interference.
Step 2 included both the main effects of depressive symptoms and pain interference, as well as the interaction between the two. To examine the interaction between depressive symptoms and pain interference, we derived equations for the simple slopes of the relationship between caregiver-reported pain interference and likelihood of no analgesic treatment for both high (þ1 standard deviation) and low (-1 standard deviation) levels of depression [34] . Analyses were conducted with SAS version 9.4 (SAS Institute, Cary, NC, USA) and IBM SPSS Statistics 22 (IBM Corporation, Armonk, NY, USA).
Results
Baseline Demographic and Clinical Comparisons
Demographic and clinical characteristics are presented for all care recipients (N ¼ 202), as well as for those with (N ¼ 113), and without (N ¼ 89) analgesic treatment (Table 1) . Almost all participants were men (98%). Approximately half were Caucasian, and the mean age was 79.3 (SD ¼ 8.3). The majority identified a spouse as the primary care partner (65%). Education level was represented across the spectrum, and just under half reported an annual income of less than $20,000.
The mean level of cognitive functioning on the Short Blessed (M ¼ 15.0, SD ¼ 7.4) suggested that all participants were cognitively impaired. Most participants scored above 10 (the clinical cutoff for depression) on the GDS: 36 (18%) scored in the severe range, 118 (64%) scored in the mild range, and 47 (23%) scored in the normal range. There were reports of some or minimal pain interference, leaving almost a third of the participants with pain interference of "quite a bit" or greater. On the basis of data from outpatient files, nearly half of the participants had no analgesic treatment.
Predictors of No Analgesic Treatment
Results of simple logistic regression analyses of each predictor separately revealed that those with greater income (odds ratio (Table 2) . Although no other variables (sociodemographic characteristics, depressive symptoms, or cognitive functioning) were significantly associated with no analgesic treatment, race was associated with no analgesic treatment at a P value of less than or equal to 0.25. Next, income, pain interference, and race were simultaneously entered into a single multiple logistic regression model. Those with greater income (OR ¼ 0.79, 95% CI ¼ 0.63-0.99), as well as those with greater pain interference (OR ¼ 0.79, 95% CI ¼ 0.63-0.99), continued to be significantly less likely to have no analgesic treatment (Table 2) .
A significant interaction between pain interference and depressive symptomology was also associated with no analgesic treatment (OR ¼ 1.04, 95% CI ¼ 1.01-1.08) ( Table 3 ). Simple slopes of the relationship between pain interference and percentage of respondents with no analgesic treatment were calculated at both higher and lower levels of depressive symptomology. The likelihood of not receiving analgesic treatment is the same among those with higher depressive symptomology, regardless of level of pain interference (b ¼ -0.02, SE ¼ 0.15, P ¼ .91). However, among those with lower levels of depressive symptomology, those who reported lower pain interference were more likely to not receive analgesic treatment compared with those who reported higher pain interference (b ¼ -0.52, SE ¼ 0.18, P ¼ 0.005). However, among those with greater depressive symptomology, there was no relationship between pain interference and the dependent variable. Figure 1 displays the percentage of participants with no analgesic treatment among the subgroup of participants within four extreme categories: lower (less than or equal to -1 SD from the mean) or higher (greater than or equal to þ1 SD from the mean) caregiver-reported pain interference and lower (LE -1 SD) or higher (GE þ1 SD) depressive symptomology. 
Discussion
This study found that nearly half (44%) of communitydwelling persons with dementia and moderate-to-severe pain received no pain medication, which is congruent with other studies that have reported that pain is undertreated in older adults with dementia [8, 9, 35] . As hypothesized, enabling and need characteristics were important factors in no analgesic treatment, with lower income and less pain interference as the main explanatory factors. These findings are congruent with the Behavioral Model of Health Service Utilization [13] and consistent with previous research that has demonstrated that individuals with fewer financial resources often have less access to healthcare [36] . It is also expected that those with less pain interference are less likely to get analgesic treatment for pain, given that medication administration is often guided by an individual's level of functioning. 
Figure 1
Percent of respondents with analgesic treatment among the subset of respondents with extreme (i.e., at least þ 1 SD from the mean) values on both pain interference and depressive symptomology (GDS) (N for all four groups ¼ 38). Bar values are as follows: lower pain interference and lower GDS ¼ 9/12 ¼ 75.00%; higher pain interference and lower GDS ¼ 0/4 ¼ 0.00%; lower pain interference and higher GDS ¼ 4/9 ¼ 44.44%; and higher pain interference and higher GDS ¼ 6/13 ¼ 46.15%. CG ¼ caregiver; GDS ¼ Geriatric Depression Scale; -1SD ¼ values of less than or equal to 1 standard deviation below the mean; þ1 SD ¼ values of greater than or equal to 1 standard deviation above the mean.
Pain Among Community-Dwelling Older Adults with Dementia
However, participants who presented with less pain interference were more likely to receive no analgesic medication only if they had lower levels of depressive symptoms. This finding is of particular importance, given that there is variability among those who experience pain interference and receive analgesic treatment. As a secondary cross-sectional analysis, we cannot draw firm conclusions regarding cause and effect based on these findings. One possible explanation for why these individuals had lower rates of analgesic treatment may be that their pain was less severe and was not deemed significant enough to treat. However, a subset of these patients with less pain interference did receive analgesic medication, and it was the subset that had higher levels of depressive symptoms. It is therefore possible that somatic symptoms associated with depressive symptoms (e.g., fatigue, sleep disturbance, poor appetite) were falsely interpreted as pain symptoms for these individuals, leading providers to administer analgesic medications when they were not actually warranted.
These data underscore the complexity underlying the decision to initiate an analgesic trial among older adults with dementia, pain, and depressive symptoms. Because dementia-associated deficits make it difficult for people with dementia to self-report their pain experiences accurately [19, 20] , it is often up to care partners and providers to determine if pain is present. Observational pain assessment is and should be the gold standard for persons with dementia [37] , yet our findings highlight that it is likely often challenging for observers to correctly interpret nonverbal behaviors, especially in care recipients who experience concurrent depressive symptoms. Although validated observational pain assessment measures have been developed (e.g., Doloplus-II), most behaviors commonly evaluated through these measures (e.g., sleep patterns, social life, somatic complaints, communication) for older adults with dementia overlap with depressive symptoms, limiting the specificity of these tools [38] . Such lack of specificity means that pain may be overtreated if depressive symptoms are mistaken for pain symptoms.
The presence of depressive symptoms likely complicates assessment and treatment for patients with dementia and concurrent pain. Our findings suggest clinicians and care partners should be cautious about the impact of pain and depressive symptoms when caring for this population. However, additional research is needed before making any definitive recommendations on how to best apply these findings to clinical practice. To best direct clinical care, future research should focus on how to reliably and validly assess concurrent pain and depressive symptoms through multiple sources, including self-report and observational pain assessment tools, physical examinations, and care partner reports. Community-dwelling persons with dementia with selfreported pain have been shown to be at higher risk for developing depression compared with their counterparts who do not report pain symptoms [39] . Perhaps it is thus reasonable to consider that this may also be true in persons who cannot self-report their pain, where observational measures must be wholly relied upon. Therefore, future research should also focus on whether depression is being appropriately assessed and treated in this population with pharmacological (e.g., SNRIs, SSRIs) and nonpharmacological approaches (e.g., behavioral interventions), rather than being misdiagnosed as pain and treated as such.
These data should be interpreted in light of a number of study limitations. First, our study was cross-sectional; therefore, we cannot infer causal relationships between the predisposing, enabling, and need characteristics selected for this study and no analgesic treatment. Longitudinal studies are needed to confirm our findings. Second, our findings were based on data drawn from a larger trial of a pain intervention for community-dwelling people with dementia; therefore, we cannot compare our findings with those that might be found in a sample of older adults with pain and without dementia. We also excluded individuals who had a recent history of behavioral disturbances, such as aggression; therefore, we cannot compare our findings with individuals who have dementia, pain, and aggression. We also cannot compare across settings (i.e., medical or long-term care facilities). Third, although proxy reports are often used to assess pain and distress and other subjective states in people with dementia, proxy reports alone have limitations, given that proxies are not always educated about behaviors that are associated with pain and distress. Because we relied on proxy reports to capture pain-related interference and depressive symptoms among patients with dementia, this is an important limitation to our study. Fourth, we focused only on one type of pain treatment (i.e., analgesic medication) and did not capture pain duration (i.e., how long patients have experienced pain symptoms) in our study sample. Therefore, it is unclear whether a patient had already trialed these medications or other treatment approaches for their pain. Other Table 3 Results of multiple logistic regression models predicting no pain medication prescribed or reported
Step 1: main effects model
Step 2: interaction model OR (95% CI) OR (95% CI)
Step factors may have been associated with different types of pain treatment outcomes, such as nonpharmacological interventions or third-wave medications (e.g., SNRIs, anticonvulsants, TCAs). In addition, although the medical records reflected documented over-the-counter medications, knowledge of actual prn (i.e., as needed) pain medication is unknown, given that people often do not report the use of over-the-counter medications. We also examined medication use across a range (i.e., six months before to six months after baseline) and did not record the exact date of medication abstraction; therefore, we could not assess whether a temporal connection exists between baseline and the abstraction date. It is possible that there is a subset of patients who may have been misclassified as receiving pain treatment during baseline, who actually received it in the six-month window following baseline. It is unclear if participation in the psychosocial intervention impacted pain medication for this subset of individuals. Fifth, the construct of pain interference may have limitations for people with dementia, given that these individuals are not usually employed and may not have significant household responsibilities. Lastly, our sample comprised mostly male veterans, which may limit the generalizability of our findings.
Despite these limitations, our study is unique, given that it is among the first to address factors associated with the undertreatment of pain in community-dwelling persons with dementia and without behavioral disturbance. Our findings indicate that older adults with dementia and low levels of pain interference are less likely to receive analgesic treatments for pain only if they have lower levels of depression. Given that the initiation of analgesic trials is often complicated by comorbid pain and depressive symptoms, future research should focus on identifying the most effective assessment and treatment procedures to best direct clinical care for this population.
